TGTX
Tg Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.05 / 10
Netural
Fund flow score is 7.63 (good) with small/medium inflows positive but large/extra‑large inflows negative, overall inflow ratio 0.47. Analyst sentiment is split (Buy and Neutral) and recent performance is mixed, leading to a cautious outlook.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-02
InstitutionJP Morgan
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for TGTX?
- TGTX holds a Bearish analyst rating, with 50% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.05/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
